We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cynata Pre-IND meeting with the US FDA completed successfullyFDA confirms Cymerus™ manufacturing dossier meets expectationsClear path determined for preclinical and clinical protocol...
Application filed with IP Australia would expand patent estate to immunotherapyCreates new opportunities in the growing field of immunotherapy and reinforces a position in oncology MELBOURNE...
http://www.fool.com.au/2015/04/13/how-to-identify-a-medical-stock-offering-blockbluster-returns-part-3/
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.03 | 14.2857142857 | 0.21 | 0.255 | 0.21 | 308264 | 0.2301488 | DE |
4 | 0.015 | 6.66666666667 | 0.225 | 0.255 | 0.17 | 589986 | 0.20068271 | DE |
12 | -0.02 | -7.69230769231 | 0.26 | 0.26 | 0.17 | 224011 | 0.20735052 | DE |
26 | -0.055 | -18.6440677966 | 0.295 | 0.295 | 0.17 | 148924 | 0.21474055 | DE |
52 | 0.11 | 84.6153846154 | 0.13 | 0.345 | 0.12 | 148070 | 0.21457047 | DE |
156 | -0.305 | -55.9633027523 | 0.545 | 0.6 | 0.105 | 112984 | 0.2315471 | DE |
260 | -0.8 | -76.9230769231 | 1.04 | 1.3 | 0.105 | 156703 | 0.50362 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions